Literature DB >> 10536990

R162W mutation of keratin 9 in a family with autosomal dominant palmoplantar keratoderma with unique histologic features.

N Mayuzumi1, T Shigihara, S Ikeda, H Ogawa.   

Abstract

Recurrent R162W mutation ofkeratin 9 has been reported in multiple families with epidermolytic hyperkeratosis (EHK)-type hereditary palmoplantar keratoderma (PPK). Recently, we have observed a family whose members showed autosomal-dominant PPK with unique histologic features such as rounded, dissociated, and slightly eosinophilic keratinocytes at the middle spinous and granular layers of epidermis, but without the distinct EHK phenotype. To investigate the genotype-phenotype correlation in this family, we searched for a mutation of keratin 9 and found R162W substitution in the coiled 1A region. This mutation was not detected in 50 control individuals. These results may further our understanding of the pathogenesis of EHK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536990     DOI: 10.1038/sj.jidsp.5640199

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  2 in total

1.  Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes.

Authors:  Alexander A Merleev; Stephanie T Le; Claire Alexanian; Atrin Toussi; Yixuan Xie; Alina I Marusina; Steven M Watkins; Forum Patel; Allison C Billi; Julie Wiedemann; Yoshihiro Izumiya; Ashish Kumar; Ranjitha Uppala; J Michelle Kahlenberg; Fu-Tong Liu; Iannis E Adamopoulos; Elizabeth A Wang; Chelsea Ma; Michelle Y Cheng; Halani Xiong; Amanda Kirane; Guillaume Luxardi; Bogi Andersen; Lam C Tsoi; Carlito B Lebrilla; Johann E Gudjonsson; Emanual Maverakis
Journal:  JCI Insight       Date:  2022-08-22

Review 2.  Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review.

Authors:  Xiaoliang Liu; Chuang Qiu; Rong He; Yuanyuan Zhang; Yanyan Zhao
Journal:  Mol Genet Genomic Med       Date:  2019-09-16       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.